Cloning of suppressor gene of metastasis using subtraction hybridization method

消减杂交法克隆转移抑制基因

基本信息

  • 批准号:
    05671026
  • 负责人:
  • 金额:
    $ 1.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1994
  • 项目状态:
    已结题

项目摘要

A gene (HFREP-1) that is overexpressed in hepatocellular carcinomas (HCCs) has been identified using a subtractive and differential cDNA cloning approach. We isolated the gene from a lambdagt10 cDNA library that was constructed from the poly(A)+-enriched RNA of a HCC specimen. The expression patterns observed in HCCs from 20 patients were classified into three types ; HFREP-1 was overexpressed in HCCs compared with non-tumorous regions (NTRs) in 55%, expressed weakly in both regions (15%) and strongly in both (30%). The largest cDNA insert contained 1231 base pairs coding 312 amino acids. The deduced protein sequence contained a hydrophobic leader peptide with a site for cleavage. The putative protein sequence showed strong homology with fibrinogen beta- and gamma- subunites and other fibrinogen-related proteins (FRPs), including four cysteine conserved residues. However, the HFREP-1 protein lacked a platelet-binding site, cross-linking region and thrombin-sensitive site, which are crucial for fibrin clot formation. The gene expression was studied in various organs in the rat and was specific to the liver, but little or none was detected in the fetal rat liver. Of the human carcinoma cell lines investigated, HFREP-1 was detected only in the HCC cell lines. We suggest that the HFREP-1 gene is a new member of the family of fibrinogens and has different features from other known FRPs and its expression is regulated oncodevelopmentally in hepatocytes.
采用消减和差异表达的基因克隆方法,鉴定了一个在肝细胞癌中过表达的基因(HFREP-1)。我们从从肝癌标本的Poly(A)+丰富的RNA中构建的lambdagt10 cDNA文库中分离到该基因。20例患者肝细胞癌组织中HFREP-1的表达可分为三种类型:HFREP-1在肝细胞癌中高表达,非肿瘤区高表达(55%),两区弱表达(15%),强表达(30%)。最大的插入片段包含1231个碱基对,编码312个氨基酸。推导出的蛋白质序列含有一个疏水的前导肽,带有一个切割位点。推测的蛋白质序列与纤维蛋白原β和γ亚基以及其他纤维蛋白原相关蛋白(FRP)有很强的同源性,包括四个半胱氨酸保守残基。然而,HFREP-1蛋白缺乏对纤维蛋白凝块形成至关重要的血小板结合部位、交联区和凝血酶敏感部位。该基因在大鼠的不同器官中都有表达,并且只在肝脏中特异表达,但在胎鼠肝脏中很少或没有检测到。在所研究的人癌细胞系中,仅在肝癌细胞系中检测到HFREP-1。我们认为HFREP-1基因是纤维蛋白原家族的一个新成员,具有不同于其他已知FRP的特征,其表达在肝细胞中受到共同发育的调节。

项目成果

期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kubota,T,et al.: "Metastatic models of human cancer xenografts in the nude mouse: The importance of orthotopic transplautation" Journal of Cellular Biochemistry. 56. 4-8 (1994)
Kubota,T,et al.:“裸鼠中人类癌症异种移植物的转移模型:原位移植的重要性”细胞生物化学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kuo,T.et al.: "Site-specific chemosensitivity of human Small-cell long carcinoma orthotopically grown compared tosc in SCIP mice" Anticancer Research. 13. 627-630 (1993)
Kuo,T.et al.:“与 SCIP 小鼠中的 SC 相比,原位生长的人类小细胞长癌的位点特异性化学敏感性”抗癌研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Furukawa, T., Kubota, T., Watanabe, M., Kuo, T., Kase, S., Saikawa, Y., Tanino, H., Teramoto, T., Ishibiki, K., Kitajima, M.and Hoffman, R.M.: "Immunochemotherapy prevents human colon cancer metastasis after orthotopic onplantation of histologically-intac
古川 T.、久保田 T.、渡边 M.、郭 T.、加濑 S.、西川 Y.、谷野 H.、寺本 T.、石壁 K.、北岛 M. 和
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Furukawa,T.et al.: "A novel“patient-like"freatment model of human pancieattc cancer constructed using orthotopic transplartation" Cancer Research. 53. 3070-3072 (1993)
Furukawa, T. 等人:“使用原位移植构建的新型“患者样”人类胰腺癌模型”Cancer Research 53. 3070-3072 (1993)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kubota, T.: "Metastatic models of human cancer xenografted in the nude mouse : The importance of orthotopic transplantation." Journal of Cellular Biochemistry. 56 (1). 4-8 (1994)
Kubota, T.:“人类癌症异种移植到裸鼠的转移模型:原位移植的重要性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUBOTA Tetsuro其他文献

KUBOTA Tetsuro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUBOTA Tetsuro', 18)}}的其他基金

Novel chmosensitivity testing using molecular dynamics responding to anticancer drugs
利用对抗癌药物的分子动力学进行新型化学敏感性测试
  • 批准号:
    17591435
  • 财政年份:
    2005
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Chemo-resistance-related genes detected by cDNA microarray
cDNA微阵列检测化疗耐药相关基因
  • 批准号:
    14571225
  • 财政年份:
    2002
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New strategy in cancel therapy with reference tomethionine-depletion
参考蛋氨酸消耗的取消治疗新策略
  • 批准号:
    07671329
  • 财政年份:
    1995
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Comparative study of concentrations of antitumor agents in serum and tumor in nude mouse and human
裸鼠与人血清及肿瘤中抗肿瘤药物浓度的比较研究
  • 批准号:
    62570579
  • 财政年份:
    1987
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了